Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
149 studies found for:    ROP
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Bevacizumab;   Procedure: Conventional Laser for ROP
2 Active, not recruiting Telemedicine Approaches to Evaluating Acute-phase ROP
Condition: Retinopathy of Prematurity
Intervention:
3 Recruiting Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity
Condition: Retinopathy of Prematurity (ROP)
Intervention: Biological: ranibizumab
4 Completed Pain Response During Examination for Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Behavioral: suck 12.5% dextrose in water 5 minutes before the procedure
5 Recruiting Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1
Condition: Retinopathy of Prematurity
Intervention: Procedure: Injection of bevacizumab intravitreal (Avastin)
6 Withdrawn Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
7 Completed Vascular Endothelial Growth Factor in Stage V ROP
Condition: Retinopathy of Prematurity
Intervention: Procedure: Open-Sky Vitrectomy
8 Recruiting IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: rhIGF-I/rhIGFBP-3
9 Completed Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Retinopathy of Prematurity;   Blindness
Interventions: Procedure: Supplemental Oxygen Management;   Procedure: Conventional Oxygen Management
10 Completed
Has Results
Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study
Condition: Retinopathy of Prematurity
Interventions: Drug: propranolol;   Drug: sucrose 5%
11 Enrolling by invitation Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
Conditions: Retinopathy of Prematurity;   Retinal Detachment;   Blindness
Interventions: Drug: ACULAR;   Drug: REFRESH TEARS;   Drug: placebo
12 Not yet recruiting ROP Screening: Comparison of Pain Using Two Eyelid Retractors
Condition: Pain During ROP Exam
Interventions: Procedure: ROP exam with spring loaded retractor;   Procedure: ROP exam with screw retractor
13 Completed Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol
14 Recruiting Inositol to Reduce Retinopathy of Prematurity
Condition: Retinopathy of Prematurity (ROP)
Intervention: Drug: myo-Inositol 5% Injection
15 Completed Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
Condition: Retinopathy of Prematurity
Intervention: Drug: intravitreal injection of 0.03ml ranibizumab
16 Completed "Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"
Condition: Light Sensitivity
Intervention: Behavioral: eye covers
17 Terminated Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
18 Completed VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V
Condition: Retinopathy of Prematurity
Intervention: Procedure: Vitrectomy
19 Completed Retinopathy of Prematurity:Summary of a Decade
Condition: Retinopathy of Prematurity
Intervention:
20 Recruiting Telemedicine Approaches to Evaluating Acute-Phase ROP eROP Implementation Project
Condition: Retinopathy of Prematurity
Intervention: Procedure: RetCam retinal Imaging used for routine care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years